Arialys Therapeutics

Home Team News Careers Contact

News

« Back to News

March 12, 2024

Drug Discovery News: Putting Out a Fire in the Brain

Figuring out that the immune system is to blame is a slow process, and sometimes comes too late for patients who have already undergone brain damage. Even once a patient is diagnosed, treatments for anti-NMDA receptor encephalitis tend to be blunt and aimed at tamping down the whole immune system.

Researchers at Arialys Therapeutics think that there’s a better way to treat the condition. The biotech company is developing a new drug, so far dubbed ART5803, to treat anti-NMDA receptor encephalitis by precisely blocking the immune system’s interactions with neurons. If their drug succeeds in animal studies and makes its way into human trials, it could change the paradigm for how physicians treat not only anti-NMDA receptor encephalitis, but also a host of psychiatric diseases.

Read the full article here.

Sign up for news updates

Thank you! Your submission has been received!

Oops! Something went wrong while submitting the form.

Follow us

©2024 Arialys Therapeutics, 11099 North Torrey Pines Rd., Ste 290, La Jolla, CA 92037